Home › All Companies › UTMD › Current Report

UTAH MEDICAL PRODUCTS INC (UTMD) — Current Report

AI-Powered SEC Filing Analysis

← All UTMD filings
Latest Current Report Filed: 2026-04-23

Key Insights

  • UTMD filed an 8-K to disclose Q1 2026 financial results and forward-looking statements via press release dated April 23, 2026, indicating earnings announcement on the same day as filing.
  • The filing references a press release attachment (Exhibit 99.1) containing the actual financial information and 2026+ guidance, but the detailed results are not included in the 8-K itself, limiting immediate visibility into performance metrics.
  • CEO Kevin L. Cornwell signed the filing, confirming leadership continuity and direct accountability for the disclosed financial information and forward guidance.
  • The company furnished information under Item 2.02 with standard safe harbor disclaimers, meaning the results are not incorporated by reference into other SEC filings and carry reduced liability exposure.
Sentiment: Neutral Significance: 4/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-04-23. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.